CR20150040A - ANTI-CD79B ANTIBODIES AND IMMUNOCATE PLAYERS - Google Patents

ANTI-CD79B ANTIBODIES AND IMMUNOCATE PLAYERS

Info

Publication number
CR20150040A
CR20150040A CR20150040A CR20150040A CR20150040A CR 20150040 A CR20150040 A CR 20150040A CR 20150040 A CR20150040 A CR 20150040A CR 20150040 A CR20150040 A CR 20150040A CR 20150040 A CR20150040 A CR 20150040A
Authority
CR
Costa Rica
Prior art keywords
immunocate
players
cd79b antibodies
compositions
substances
Prior art date
Application number
CR20150040A
Other languages
Spanish (es)
Inventor
Yvonne Chen
Mark Dennis
David Dornan
Kristi Elkins
Jagath Reddy Junutula
Andrew Polson
Bing Zheng
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52012059&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20150040(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2008/070088 external-priority patent/WO2009012268A1/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of CR20150040A publication Critical patent/CR20150040A/en

Links

Abstract

La presente invención se centra en composiciones de sustancias útiles para el tratamiento de tumores hematopoyéticos en mamíferos, así como los métodos para usar dichas composiciones de sustancias con el mismo objetivo.The present invention focuses on compositions of substances useful for the treatment of hematopoietic tumors in mammals, as well as methods for using said compositions of substances for the same purpose.

CR20150040A 2007-07-16 2015-01-29 ANTI-CD79B ANTIBODIES AND IMMUNOCATE PLAYERS CR20150040A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US95005207P 2007-07-16 2007-07-16
US2513708P 2008-01-31 2008-01-31
US3279008P 2008-02-29 2008-02-29
PCT/US2008/070088 WO2009012268A1 (en) 2007-07-16 2008-07-15 Anti-cd79b antibodies and immunoconjugates and methods of use

Publications (1)

Publication Number Publication Date
CR20150040A true CR20150040A (en) 2015-02-18

Family

ID=52012059

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20150040A CR20150040A (en) 2007-07-16 2015-01-29 ANTI-CD79B ANTIBODIES AND IMMUNOCATE PLAYERS

Country Status (2)

Country Link
CL (1) CL2012002118A1 (en)
CR (1) CR20150040A (en)

Also Published As

Publication number Publication date
CL2012002118A1 (en) 2012-11-30

Similar Documents

Publication Publication Date Title
ECSP109878A (en) ANTI-CD79B ANTIBODIES AND IMMUNOCATE PLAYERS AND METHODS OF USE OF THE SAME
ECSP109940A (en) ANTI-CD79B ANTIBODIES AND HUMANIZED IMMUNOCATE PLAYERS AND METHODS OF USE
CO6430468A2 (en) ANTI-FCRH5 AND IMMUNOCATE PLAYING ANTIBODIES AND METHODS OF USE
ECSP078013A (en) MEK HETEROCYCLIC INHIBITORS AND METHODS OF USE OF THEM
CO6382189A2 (en) ANTI-CD79B ANTIBODIES AND IMMUNOCATE PLAYERS AND METHODS OF USE
CY1118250T1 (en) CERTAIN TRIAZOLOPYRAZINS, THEIR COMPOSITIONS AND METHODS FOR USE
CR10372A (en) ANTI-TAT226 ANTIBODIES AND IMMUNOCATE PLAYERS
CR20130455A (en) COMPOSITIONS FOR TUMOR TREATMENT
EA200970737A1 (en) OXABICYCLOPTANES AND OXABICYCLOPTENS
EA200970987A1 (en) TRICYCLIC NITROGEN-CONTAINING COMPOUNDS AS ANTIBACTERIAL AGENTS
CL2008001633A1 (en) Compounds derived from pyrrolidin-3-carboxamide; pharmaceutical composition; and use as erk inhibitors for the treatment of cancer.
CY1116261T1 (en) ANTIBODIES AND IMMUNITIES AND THEIR USES
AR066042A1 (en) MOLECULES AND METHODS TO MODULATE PROTEIN CONVERTASA-SUBTILISIN / QUEXIN TYPE 9 (PCSK9)
EA201170252A1 (en) AMIDOPHENOXINDAZOLES AS C-MET INHIBITORS
CO6321189A2 (en) BENCEN-SULFONAMIDE TIAZOL AND OXAZOL COMPOUNDS
CL2012002189A1 (en) Compounds derived from substituted pyrrolidine-2-carboxamides; mdm2-p53 interaction inhibitors; pharmaceutical composition; and its use for the treatment of cancer, particularly solid tumors.
CO6450665A2 (en) ANTI-FGFR3 ANTIBODIES AND METHODS THAT USE THEM
EA200701396A1 (en) TRIAZOLOPHTHALASINS AS PDE-2 INHIBITORS
SV2011003834A (en) COMPOSITIONS AND METHODS FOR ANTIBODIES GOING TO COMPLEMENT PROTEIN C5
UY32049A (en) CMET INHIBITORS
NI201200080A (en) IL-17A ANTAGONISTS
CL2011000527A1 (en) Compounds derived from benzofuran; pharmaceutical composition that includes them; and their use in the treatment of hepatitis c.
EA200900781A1 (en) 4-PHENYPYRANE-3,5-DIONA, 4-PHENYLTIOPYRANE-3,5-DIONA AND CYCLOHEXANTHRION, AS NEW HERBICIDES
CR11361A (en) MOLECULES AND METHODS TO MODULATE THE COMPLEMENT COMPONENT
CY1118062T1 (en) COMPOSITIONS FOR TREATMENT OF MARINE AND VOMITABLE CENTRAL ORIGIN